Show results for
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Environmental
- Chemical & Pharmaceuticals
- Energy
- Banking & Finance / Insurance / Legal
- Aerospace & Air Transport
- Retail
- Waste and Recycling
- Agriculture
- Health and Safety
- Air and Climate
- Soil and Groundwater
- Manufacturing, Other
- Food and Beverage
- Construction & Construction Materials
Biotherapeutics Suppliers Serving Kiribati
40 companies found
Premium
based inFramingham, MASSACHUSETTS (USA)
SCIEX empowers you to solve the most impactful analytical challenges in quantitation and characterization in environmental testing. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field ...
Biotransformation studies are necessary for both small and large molecule therapeutics. From fast and efficient metabolic stability and soft spot analysis to in-depth, comprehensive identification of metabolites and catabolites in a sample, SCIEX ...
based inWürzburg, GERMANY
Toleris Biotherapeutics GmbH is a biotechnology company based in Würzburg, Germany. The company specializes in the development of innovative biotherapeutic solutions aiming to advance the field of medicine through cutting-edge scientific research. ...
AIM Bio has developed a platform of Autoimmunity Modifying Biologicals (AIM Biologicals) that uses soluble, near-physiological proteins to induce selective, antigen-specific immune tolerance. These proteins mimic a natural process observed in ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
based inCambridge, MASSACHUSETTS (USA)
Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...
based inBiel/Bienne, SWITZERLAND
We work for a world where regenerative medicine is accessible to everyone. MimiX develops and commercializes a proprietary technology to foster scientific discoveries and clinical translation. MimiX biotherapeutics introduces Sound Induced ...
KYTO is a chemically defined, synthetic hydrogel that bears biologically active sites. An MMP-cleavable crosslinker allows for potential cell spreading and migration. The hydrogel can be customised to bear a cell adhesive peptide, RGD, to further ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
Destiny Pharma is working in collaboration with SporeGen Limited, a UK biotechnology company working exclusively on Bacillus and its applications, to co-develop SporeGen’s SPOR-COV™ product as a novel, preventive treatment for COVID-19. ...
based inSingapore, SINGAPORE
Esco provides standardized platforms with built-in configurations while ensuring operational parameters are not compromised. This enables the manufacture of internationally compliant pharmaceuticals, nutraceuticals, and cosmeceuticals. Esco Pharma‘s ...
based inHalle, GERMANY
Navigo Proteins is a successful and steadily growing, privately held protein engineering company, which develops best-in-class custom precision affinity ligands, based on selected protein scaffolds. We partner with pharma, biotech and life science ...
Navigo Proteins’ Affilin® platform benefits from the inherent engineerability, stability, safety, and ease of manufacturability. Our Precision Targeting unit comprises a versatile toolbox to custom-build selective ...
based inSeattle, WASHINGTON (USA)
Nexelis is your partner for assay and biomarker development, advanced bioanalytical and laboratory testing, and translational immunology. As the leading specialty laboratory, we have unrivaled expertise in immunology, specifically in the areas of ...
Including Pharmacokinetics and Immunogenicity. Designed to be an extension of your laboratory, Nexelis, a Q² Solutions Company, supports bioanalysis in all phases with agile assay development to validation mindset. Whether we design a custom ...
based inBoston, MASSACHUSETTS (USA)
Harmonizing Science & Data to Create a Better Future, Together. From developing new personalized and preventive patient treatment solutions to revising climate change - Dotmatics solutions are at the core of scientific innovation. At Dotmatics, we ...
based inBoca Raton, FLORIDA (USA)
Entero Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing targeted, orally delivered therapies for gastrointestinal (GI) diseases. At the core of its research are three proprietary technologies. Latiglutenase is an ...
Latiglutenase, known as IMGX003, is an orally administered formulation comprising two recombinant proteases specifically targeting gluten proteins. It works by breaking down these proteins into smaller, non-reactive fragments, offering an adjunctive ...
based inFarmington, CONNECTICUT (USA)
Intus Biosciences’ world-leading cidentifies bacteria and delivers answers about the microbiome with unprecedented detail, accuracy and scale. Its patented, validated Titan-1™ platform combines high-throughput assay and analysis technology and is ...
based inGlenview, ILLINOIS (USA)
Asahi Kasei Bioprocess is a global solution provider to biologics manufacturing industry. We aim to help biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally ...
Planova Virus Removal Filters are specialized filtration solutions designed to provide reliable viral clearance in biopharmaceutical manufacturing. These filters, having been in use since 1989, are renowned for their robust performance and ...
based inPhiladelphia, PENNSYLVANIA (USA)
With extensive experience optimising processes for analytical, production and R&D laboratories across multiple industries and regulatory environments, we provide consistent, quality informatics solutions. We operate on a truly global basis, serving ...
qPCR system for quantitation of residual plasmid DNA. Multiplex assay that targets all kanamycin resistance (KanR) gene alleles common in bioproduction. Highly specifi c quantitation through innovative DNA-free master mix. Highly sensitive ...
based inDreieich, GERMANY
Biotest - innovation in haematology, clinical immunology and intensive care medicine. Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and ...
based inVictoria, BRITISH COLUMBIA (CANADA)
IPA (ImmunoPrecise Antibodies NASDAQ: IPA ) is a biotherapeutic research company that brings industry leading antibody discovery services and complex artificial intelligence technologies together - to lead its pharmaceutical partners into the era of ...
based inRedmond, WASHINGTON (USA)
SystImmune Inc. is a biopharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug conjugates (ADCs). Our objective is to create biologics that ...
based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
![Ibio - Model 100 - Idiopathic Pulmonary Fibrosis [IPF] Therapeutics](https://d32zuqhgcrpxli.cloudfront.net/eyJidWNrZXQiOiJlZS1maWxlcyIsImtleSI6ImZpbGVzLzEyNTA4Ny9wcm9kdWN0cy84NTMxMzQvMTI1MDg3XzJfMjAyMzAyMTMwNjEwNTM5ODQxNzI5X3Jhdy5wbmciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY29udGFpbiIsImJhY2tncm91bmQiOnsiciI6MjU1LCJnIjoyNTUsImIiOjI1NSwiYWxwaGEiOjF9LCJ3aWR0aCI6MTQzLCJoZWlnaHQiOjEwMn19fQ== "Ibio - Model 100 - Idiopathic Pulmonary Fibrosis [IPF] Therapeutics")
Idiopathic pulmonary fibrosis [IPF] is a form of progressive pulmonary fibrosis, or abnormal scarring of the lungs. As the disease progresses, the increased scarring leads to decreasing transfer of oxygen into the bloodstream, and ultimately, ...
based inSanta Barbara, CALIFORNIA (USA)
More than 40 years ago, Wyatt Technology's scientists invented the very first commercial light scattering instruments incorporating lasers as their light source. We've been defining and redefining the state-of-the-art laser light scattering ...
based inGijón, SPAIN
Our mission is to develop novel technologies and next generation live biotherapeutic products providing innovative solutions to health care by harnessing the treasure of the human microbiota. We are developing a novel class biotherapeutic products ...
Microviable Therapeutics is developing novel technologies and next generation biotherapeutic products by harnessing the treasure of the human microbiota generating innovative solutions that enable to address unmet challenges in ...